Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,962,310
-
Share change
-
-161,796
-
Total reported value
-
$2,049,732
-
Price per share
-
$0.69
-
Number of holders
-
23
-
Value change
-
-$112,090
-
Number of buys
-
4
-
Number of sells
-
7
Institutional Holders of Sensei Biotherapeutics, Inc. - COM (SNSE) as of Q4 2023
As of 31 Dec 2023,
Sensei Biotherapeutics, Inc. - COM (SNSE) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,962,310 shares.
The largest 10 holders included
Newtyn Management, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Duquesne Family Office LLC, BANK OF AMERICA CORP /DE/, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., and NORTHERN TRUST CORP.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.